![Damian Wheeler](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/experts/Damian-Wheeler-CEO-Translucence-Biosystems.jpg/fit-in/500x500/filters:no_upscale())
![](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/partners/Translucence-Bio.png)
Damian Wheeler
CEO,
Translucence Biosystems
Damian Wheeler is the co-Founder and CEO of Translucence Biosystems. As a neuroscientist with more than 25 years of research experience, both in academia and in drug discovery, Damian’s focus is on developing and commercializing next-generation technologies to advance neuroscience research and accelerate CNS drug discovery. During his Ph.D. studies at McGill University and Post-Doc at Stanford, Damian became a leading expert in the signaling mechanisms by which neuronal activity activates gene transcription. He then spent 9 years at Dart NeuroScience developing cognition- enhancing drugs that engage these mechanisms. In mid-2018, Damian co-founded Translucence Biosystems with Sunil Gandhi and Ricardo Azevedo.
Sessions